Presently, Shefali Agarwal occupies the position of Chairman, President & Chief Executive Officer of Onxeo SA.

She is also on the board of Fate Therapeutics, Inc. and Gritstone bio, Inc.

Dr. Agarwal previously was Chief Medical Officer at SQZ Biotechnologies Co. and Executive VP, Chief Medical & Development Officer at Epizyme, Inc.

Dr. Agarwal received a doctorate from Karnataka University, a graduate degree from The Johns Hopkins University and a graduate degree from Merrick School of Business.